ROSA T ARTOLA
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology MISSION HILLS, CA NPI 1962848978
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology CA ABBVIE INC. All categories
General Payments — all program years on this page
$4,879.77
- Category: General Payments
- Program years: PY2018–2024
- Record count: 221
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $2,168.25 across 96 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,168.25 | 96 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $457.80 | 21 |
| Amgen Inc. | $444.84 | 20 |
| GlaxoSmithKline, LLC. | $369.61 | 15 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $229.88 | 14 |
| Janssen Biotech, Inc. | $170.55 | 8 |
| Mallinckrodt Hospital Products Inc. | $127.84 | 1 |
| UCB, Inc. | $90.19 | 4 |
| Xeris Pharmaceuticals, Inc. | $86.96 | 4 |
| Radius Health, Inc. | $28.01 | 1 |
| DEXCOM, INC. | $26.16 | 1 |
| ANI Pharmaceuticals, Inc. | $25.76 | 1 |
| DePuy Synthes Sales Inc. | $20.67 | 1 |
| Genentech USA, Inc. | $19.98 | 1 |
| PROGENICS PHARMACEUTICALS, INC. | $19.94 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.90 | 1 |
| Novo Nordisk AS | $16.70 | 1 |
| Kiniksa Pharmaceuticals International, plc | $13.46 | 1 |
By program year
Records — PY2024 (96)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.